Active Ingredient History
Valbenazine, sold under the brand name Ingrezza, is a medication used to treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bipolar Disorder (Phase 4)
Cerebral Palsy (Phase 3)
Depressive Disorder, Major (Phase 4)
Dermatology (Phase 4)
Developmental Disabilities (Phase 4)
Dyskinesias (Phase 3)
Healthy Volunteers (Phase 1)
Huntington Disease (Phase 3)
Intellectual Disability (Phase 4)
Psychotic Disorders (Phase 4)
Schizophrenia (Phase 4)
Tardive Dyskinesia (Phase 4)
Torticollis (Phase 4)
Tourette Syndrome (Phase 2)
Trichotillomania (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue